Publications
Poems syndrome: consolidation with autologous stem cell transplantation
Annie K. Baa Santosh K. Chellapuram Atul Sharma Prabhat Singh Malik Ranjit Kumar Sahoo Ahitagni Biswas Sanjay Thulkar S. T. Arun Raj Rakesh Kumar Saumyaranjan Malik Lalit Kumar In POEMS syndrome, the primary aim of treatment is to target plasma cells and suppress the production of the toxic monoclonal protein. Autologous stem cell transplantation (ASCT) [5], melphalan [6], immunomodulatory agents(thalidomide/lenalidomide) [7,8] and bortezomib, [9] etc., had good therapeutic effects in clinical application.
